[1] 钟益刚 ,徐海鹰. 缺血修饰白蛋白检测在冠心病中的应用进展[J].国际心血管病杂志,2010,37(4):225-228.
[2] 丛玉隆,朱士俊.检验医学面临的挑战与学科建设和管理[J].中华检验医学杂志,2002,25(2):116-118.
[3] Clinical and Laboratory Standards Institute. How to define and determine reference intervals in the clinical laboratory; approved guideline[S]. C28-A2, CLSI, 2000.
[4] 吴卫华,易建华. 冠心病生化标志物多项联合检测的互补效应探讨[J].检验医学,2012,27(5):361-363.
[5] Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report[J].J Emerg Med,2000,19(4):311-315.
[6] Defilippi C,Yoon S,Ro A,et al. Early detection of myocardial ischemia by a novel blood based biomarker:the kinetics of ischemia modified albumin[J].J Am Coll Cardiol,2003,45(suppl A):340a.
[7] 崔丽艳,李 晶,张 捷.北京地区汉族人群缺血修饰白蛋白参考范围的建立[J].中国误诊学杂志,2008,8(26):6301-6303.
[8] Govender R,De Greef J,Delport R,et al. Biological variation of ischaemia-modified albumin in healthy subjects[J].Cardiovasc J Afr,2008,19(3):141-144.
[9] 刘泽金,李 栋,管 青,等.武汉地区缺血修饰白蛋白参考区间的建立[J].检验医学,2011,26(1):12-15.
[10] 谢 琳,易 鸣,吴明香,等.缺血修饰白蛋白在急性冠脉综合征早期诊断的临床应用[J].现代医药卫生,2011,27(15):2267-2268.
[11] 张茉莉,武英伟,孟广伟,等.承德地区缺血修饰白蛋白参考区间的建立[J].河北医药,2012,34(20):3153-3154.